Pregledni rad
https://doi.org/10.1515/aiht-2017-68-3005
Forgotten public health impacts of cancer – an overview
Susana Viegas
orcid.org/0000-0003-1015-8760
; Environment and Health Research Group, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa, Portugal
Carina Ladeira
orcid.org/0000-0001-5588-0074
; Environment and Health Research Group, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa, Portugal
Ana Costa-Veiga
orcid.org/0000-0002-5183-9872
; Environment and Health Research Group, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa, Portugal
Julian Perelman
; Public Health Research Center, Escola Nacional de Saúde Pública, Universidade NOVA de Lisboa, Portugal
Goran Gajski
; Institute for Medical Research and Occupational Health, Zagreb, Croatia
Sažetak
Cancer is one of the diseases of greatest concern in developed countries and much effort has been invested in discovering and developing therapeutics for curing cancer. Despite the improvements in antineoplastic therapeutics in the last decades, cancer is still one of the most harmful diseases worldwide. The global burden of cancer also implies financial costs: these can be direct costs, such as those related to treatment, care, and rehabilitation and indirect, which include the loss of economic output due to missed work (morbidity costs) and premature death (mortality costs). There are also hidden costs such as health insurance premiums and nonmedical expenses that are worth noting. This paper intends to present an overview of the generally forgotten impacts that the increasing number of cancer cases can have on the environment, workers who handle antineoplastic drugs, and health services. The knowledge available of each of the impacts will be addressed and discussed regarding the expected development. Overall, lessons learnt reflect on the impact of cancer through aspects not commonly evidenced in the literature or even considered in socio-economic analysis, in part due to the fact that these are difficult to contemplate in direct and indirect cancer costs already defined. Attention may be drawn to the need of continuous investment in prevention to reduce the negative impact on the environment, and in the health of workers who handle antineoplastic drugs for patients’ treatment.
Ključne riječi
costs of cancer; global burden; occupational health
Hrčak ID:
191136
URI
Datum izdavanja:
20.12.2017.
Posjeta: 1.884 *